Fig. 1. Three main axes of brain disease categories during a lifespan

Slides:



Advertisements
Similar presentations
Objective 11-2 (II) “..Discuss changes in sensory abilities and health (including frequency of dementia) in older adults.
Advertisements

Unit 4 Psychology Plasticity of the brain. Brain Plasticity The brain’s ability to reorganise and relocate neural pathways based on new experiences and.
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
HUNTINGTON’S DISEASE BY ERIN DALTON WHAT IS IT? A degenerative brain disorder which currently there is no cure or effective treatment for it. Huntington’s.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
The Life-Span Perspective. Since 1900, the older adult population has increased dramatically –Greatest increases up to 2040 will be in the 85-and-over.
Chapter 15 - Cognitive Disorders I.Delirium Acute, temporary impairment in perception & cognition Fluctuating course.
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Notes: Assignment 4 due next Thursday Will have exam review questions next week Class questions.
Growth and development during Childhood. We can divide childhood into two parts:  Early Childhood (2 years to 6 years)  Later Childhood (6 years to.
Exercise Why Do We Do It?.
The Revolution in Brain Science Neuroplasticity and Neurogenesis.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Diseases/Disorders of the Nervous System. Categories of Conditions Trauma Structural abnormalities Degenerative Infectious Mental Health.
Since Last Discussion: XII: Experience and Critical Periods (aka, Plastics) XIII: Brain Diseases I XIV: Brain Diseases II XV: Genetics and Human Brains:
Development and Plasticity of the Brain
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Lifespan Perspective Overview Chapter 10: adolescence and adulthood-
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
Huntington’s Chorea Learning Objective – to know that Huntington’s is inherited via a dominant allele and the symptoms of the disease.
Understanding Adulthood. Defining Adulthood In Australia adulthood is defined from 18 years of age onwards and is often seen as the time when a person.
AREA OF STUDY 2 MEMORY UNIT 3 THE CONSCIOUS SELF.
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Chapter 17 Cognitive Impairment, Alzheimer’s Disease, and Dementia.
Module 11 Section 2 Health, Dementia and Alzheimer’s Disease (Pages 175 – 177) Armyn Padilla Kyana Robinson Sophia Oh.
What is Alzheimer’s disease? – Causes, Symptoms & Treatment?
LEARNING MOTOR SKILLS (VOCABULARY).  The ability to change body positions quickly and keep the body under control when moving.
Alzheimer Disease: An Overview. What is Dementia? Dementia is a set of symptoms, which includes loss of memory, understanding, and judgment.
Neurotransmitters.
Daniel Smith Wellness Programs – keeping your workforce healthy
Module 7.3 Movement Disorders
Fig. 2. Neuroprotective effects of ex-4 through the G protein-coupled GLP-1 receptor. (A) Infarct volume was assessed by TTC staining after tMCAO in rats.
Fig. 4. TGF-α is one of the major cytokines in M2 conditioned media
Disorders of Aging and Cognition
Fig. 1. In situ hybridization analysis for detecting endogenous mBest1 transcript in whole-brain region. In situ hybridization results from coronal (top.
Fig. 2. Severities of seizures by durations and daily frequency at different time points. (A) An example of seizure activity in EEG recording. (B) Seizure.
Music Therapy and How It Can Benefit Individuals with Alzheimer’s Disease Joni Pappas MA, MT-BC.
Fig. 6. Akt inhibitor IV reduced the activity of the NF-κB promoter in postconditioning. NF-κB activity was detected by a reporter gene assay in bEnd.3.
Unit 2 Review The Lifespan
PSY 103 ASSIST Education for Service-- psy103assist.com.
Higher Levels of Anxiety
Unit 2 Review The Lifespan
Adulthood and Aging.
INTRODUCING 3 DISEASES THAT AFFECTS THE NERVE SYSTEM
How do systems control the body ?. Parts of brain : Brain stem : blood pressure, heartbeat, respiration, and digestion. Cerebellum : control balance and.
Thinking About Psychology: The Science of Mind and Behavior 2e
Alzheimer's.
Lorenz Studer, Elsa Vera, Daniela Cornacchia  Cell Stem Cell 
Ninth Edition in Modules
How do cognitive abilities change over time?
Notes Ch. 11g Nervous System II.
Mental Health Across the Lifespan
Fig. 1. Ca2+-dependent spike frequency adaptation and adaptation index
Fig. 3. Relationship between the generalization of conscious feeling induced by fear conditioning and individual anxiety (or depression) level. To determine.
Fig. 3. Comparing between source localization algorithms
Fig. 2. Infarct size and mNSS, weight change of animals with oral gavage of HSA and saline. (A) TTC staining of the individual brain was shown that the.
Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery.
Fig. 3. GABA content was increased in reactive astrocytes from 3D culture and hippocampal brain slice. (A) Immunostaining of neuron-astrocyte 3D co-culture.
Fig. 1. HFD-induced obesity in C58BL/6 mice and decrease of general and motor behavior in HFD-fed mice. (A) HFD-fed, 5-week-old C57BL/6 mice (n=6/group)
Fig. 2. TH expression is decreased in mice with HFD-induced obesity
Fig. 2. Disease state-specific alteration of activity-dependent BDNF secretion from cortical axons. (A) Average fluorescence changes with time (ΔFt/F0)
Fig. 4. Chronic microwave treatment produced changes in glucose and corticosterone levels in blood. (A) Blood glucose levels of mice subjected to chronic.
Fig. 10. Summary of astrocyte specificity and coverage of hGFAP-CreERT2 in various brain regions. (A) Schematic sagittal section diagram shows heterogeneous.
Fig. 4. A theoretical model of a neural interfacing system to recover neural functions after brain injuries by neuro-prosthetic treatments. A schematic.
Fig. 2. GABAergic signaling in pathological states
Fig. 4. Analysis of parvalbumin positive neurons in DLX5/6-cre mouse
Fig. 7. Apoptotic cell death was evaluated via TUNEL
Fig. 1. The brain of Octopus minor. (A) Left: a live specimen of O
Fig. 5. Phagocytosis of zymosan particles by BV2 cells
Presentation transcript:

Fig. 1. Three main axes of brain disease categories during a lifespan Fig. 1. Three main axes of brain disease categories during a lifespan. During the course of aging, the flexibility of living organisms and their ability to regenerate neuronal cells decreases. In the early stages of life, curable developmental diseases are the rule owing to the high plasticity and capacity for regeneration that prevail during this period. As people age and became adults, various mood-associated disorders dominate as the flexibility of the brain decreases owing to the stresses and pressure of life. Finally, in the later stages, the brain is rigid, reflecting the aging of our body. People at this stage often suffer from degenerative disorders, such as dementia and movement disorders. Fig. 1. Three main axes of brain disease categories during a lifespan. During the course of aging, the flexibility of living organisms and their ability to regenerate neuronal cells decreases. In the early stages of life, curable developmental diseases are the rule owing to the high plasticity and capacity for regeneration that prevail during this period. As people age and became… Exp Neurobiol. 2017 Jun;26(3):122-131. https://doi.org/10.5607/en.2017.26.3.122